1. Home
  2. RCMT vs CGEN Comparison

RCMT vs CGEN Comparison

Compare RCMT & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$27.77

Market Cap

196.0M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.08

Market Cap

191.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
CGEN
Founded
1971
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.0M
191.1M
IPO Year
1997
2001

Fundamental Metrics

Financial Performance
Metric
RCMT
CGEN
Price
$27.77
$2.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$36.00
$5.00
AVG Volume (30 Days)
74.5K
411.7K
Earning Date
04-03-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
N/A
EPS
0.52
N/A
Revenue
$186,737,000.00
N/A
Revenue This Year
$11.89
N/A
Revenue Next Year
$12.46
$75.09
P/E Ratio
$52.83
N/A
Revenue Growth
5.83
N/A
52 Week Low
$17.26
$1.30
52 Week High
$32.50
$3.24

Technical Indicators

Market Signals
Indicator
RCMT
CGEN
Relative Strength Index (RSI) 66.52 40.66
Support Level $17.77 $1.98
Resistance Level $32.39 $2.35
Average True Range (ATR) 1.18 0.09
MACD 0.47 0.02
Stochastic Oscillator 88.80 65.82

Price Performance

Historical Comparison
RCMT
CGEN

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: